Inhibition of Transmural Inflammation in Crohn’s Disease by Orally Administered Tumor Necrosis Factor-Alpha Deoxyribozymes-Loaded Pyroptosis Nanoinhibitors-Reference-Cited by-同舟云学术

Inhibition of Transmural Inflammation in Crohn’s Disease by Orally Administered Tumor Necrosis Factor-Alpha Deoxyribozymes-Loaded Pyroptosis Nanoinhibitors

Published:2024-07-25 Issue:31 Volume:16 Page:40499-40514
ISSN:1944-8244
Container-title:ACS Applied Materials & Interfaces
language:en
Short-container-title:ACS Appl. Mater. Interfaces

Author:

Li Zhun¹,Zhu Zhenxing²,Zhou Dongtao³,Chen Yusheng¹,Yin Yi⁴,Zhang Zhibin³,Yang Jingjing⁵^ORCID,Gao Yanfeng⁶,Zhu Weiming¹,Song Yujun³^ORCID,Li Yi¹

Affiliation:

1. Department of General Surgery, Nanjing Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210023, China

2. Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing 210029, China

3. College of Engineering and Applied Sciences, State Key Laboratory of Analytical Chemistry for Life Science, Nanjing University, Nanjing 210023, China

4. Department of General Surgery, Affiliated Drum Tower Hospital, Medical School, Nanjing University, Nanjing 210008, China

5. Department of Biochemistry and Molecular Biology, School of Medicine & Holistic Integrative Medicine, Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Nanjing University of Chinese Medicine, Nanjing 210023, China

6. School of Medical Imaging, Wannan Medical College, Wuhu 241002, China

Funder

State Key Laboratory of Analytical Chemistry for Life Sciences

Jiangsu Provincial Key Research and Development Program

National Key Research and Development Program of China

Natural Science Foundation of Jiangsu Province

National Natural Science Foundation of China

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acsami.4c05921

Reference58 articles.

1. The IBD interactome: an integrated view of aetiology, pathogenesis and therapy

2. Crohn's disease

3. The cost of inflammatory bowel disease in high-income settings: a Lancet Gastroenterology & Hepatology Commission

4. Global Burden of Digestive Diseases: A Systematic Analysis of the Global Burden of Diseases Study, 1990 to 2019

5. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies